Skip to main content
. 2019 Nov 19;5(4):53. doi: 10.3390/ncrna5040053

Figure 3.

Figure 3

Differential expression levels of miR-205 among breast cancer subtypes. The expression of miR-205-5p is lower in HER2+ than luminal A/B, and triple negative breast cancer (TNBC) has the lowest miR-205-5p level compared with the other subtypes. Decreasing miR-205-5p expression level is associated with enhanced metastatic capability and worsening of patient survival.